Hakan OĞUZTURK, Gulhan Kurtoglu CELİK, Semih KORKUT, Afşin Emre KAYIPMAZ

COVID-19'LU BİR HASTADA VARİSELLA ZOSTER KO ENFEKSİYONU

COVID-19 Hastalığı, asemptomatik enfeksiyondan kritik hastalığa kadar geniş bir klinik yelpazeye sahiptir, azsayıda COVID-19 hastası ölümle sonuçlanabilecek ciddi hastalıklar yaşar. Literatürde COVID-19 hastalığındakutanöz lezyonlarla ilgili daha az bilgi mevcuttur. 42 yaşında, bilinen hastalığı olmayan erkek hasta, 3 gün öncebaşlayan ateş, kuru öksürük, halsizlik, kızarıklık ve baş ağrısı şikayetlerinden sonra acil servisimize geldi. Buyazıda, COVID-19 enfeksiyonunun zona zoster gibi diğer hastalıklarda da görülebileceği konusunda farkındalıkyaratmayı amaçladık.

VARICELLA ZOSTER CO-INFECTION IN A PATIENT WITHCOVID-19

COVID-19 Disease has a wide clinical spectrum from asymptomatic infection to critically ill, a small number of COVID-19 patients experience a severe illness that can result in death. Less information is available in the literature regarding cutaneous lesions in COVID-19 disease. A 42-year-old male patient with no known disease came to our emergency department after fever, dry cough, weakness, rashes, and headache complaints that started 3 days ago. In this article, we aimed to report this case to raise awareness that COVID-19 infection can be accompanied by other diseases such as zona zoster.

PDF

___

1. Arvin AM. Varicella-zoster virus. Clinical Microbiology Reviews. 1996;9(3):361-81 (doi:10.1128/cmr.9.3.361)
2. Elsaie ML, Youssef EA, Nada HA. Herpes zoster might be an indicator for latent COVID 19 infection. Dermatol Ther. 2020;33(4):e13666 (doi:10.1111/dth.13666).
3. Saati A, Al-Husayni F, Malibari AA, Bogari AA, Alharbi M. Herpes Zoster Co-Infection in an Immunocompetent Patient With COVID-19. Cureus. 2020;12(7):e8998 (doi:10.7759/cureus.8998).
4. Oguzturk H, Kayipmaz AE. Coronaviruses. In: Oguzturk H, ed. COVID-19 and Emergency Medicine. Ankara: Turkish Clinics; 2020:1-4.
5. Dağcıoğlu BF, Keskin A. Data Comparison of Turkey, Europe, and USA During COVID-19 Process: A Cross-Sectional Study. Ankara Medical Journal. 2020;20(2):360-9 (doi:10.5505/amj.2020.02328).
6. Rittirsch D, Flierl MA, Ward PA. Harmful molecular mechanisms in sepsis. Nat Rev Immunol. 2008;8(10):776-87 (doi:10.1038/nri2402)